Pfizer Inc. (NYSE:PFE)

The financial data reveals a significant cyclic pattern in profitability, characterized by a period of strong performance, a severe contraction leading to negative returns, and a subsequent recovery phase. A marked volatility is observed across all margins and return metrics between late 2023 and mid-2024.

Gross Profit Margin

A growth trend is observed from April 2022, peaking at 69.61% in July 2023. This was followed by a contraction to a low of 58.09% in March 2024. A strong recovery occurred thereafter, with margins expanding to a peak of 74.33% by December 2025 and maintaining a high level of 73.51% through March 2026.

Operating and Net Profit Margins

Both metrics exhibited a synchronized and sharp decline starting in July 2023. Operating profit margin fell from 28.13% to a trough of -4.19% in June 2024, while net profit margin similarly dropped from 27.38% to -4.62% in the same period. A recovery began in September 2024, with operating margins stabilizing around 22.96% and net margins settling at 11.83% by March 2026.

Return on Equity (ROE)

ROE demonstrated high initial values, exceeding 30% throughout much of 2022. A steep downward trajectory followed, resulting in negative returns that peaked at -2.96% in June 2024. While a recovery was observed, peaking at 12.12% in June 2025, the ratio ended the period at 8.31%, significantly lower than the 2022 baseline.

Return on Assets (ROA)

ROA mirrored the trajectory of ROE, declining from a high of 15.91% in December 2022 to a low of -1.20% in June 2024. The subsequent recovery was more modest than that of the profit margins, reaching a secondary peak of 5.22% in June 2025 before declining to 3.61% by March 2026.

Overall, while gross margins recovered to levels exceeding the initial period, the operating and net margins, as well as returns on assets and equity, did not return to their 2022 peaks, suggesting a structural shift in the profitability profile despite the recovery from the mid-2024 lows.

The analysis of gross profit margins reveals a cyclical pattern characterized by an initial period of expansion, a sharp mid-term contraction, and a subsequent sustained recovery to peak levels.

Initial Margin Expansion (April 2022 – July 2023)

A consistent upward trajectory is observed during this period, with the gross profit margin increasing from 60.35% to a peak of 69.61%. This growth occurred despite fluctuations in total revenue, suggesting improved cost efficiencies or a shift in product mix toward higher-margin offerings.

Contraction and Volatility (October 2023 – June 2024)

A significant decline in profitability is evident starting in the fourth quarter of 2023, where the margin dropped sharply to 58.10% by December 2023. This period coincides with the lowest recorded gross profit of 4,223 million USD in October 2023. The margin remained suppressed near the 58% level through June 2024, indicating a period of heightened cost pressure or reduced pricing power.

Recovery and Optimization (September 2024 – March 2026)

A robust recovery phase began in September 2024, with the margin climbing to 67.73% and continuing a steady ascent to a maximum of 74.33% by December 2025. This recovery is marked by a decoupling of margins from revenue volume; while revenues fluctuated between 13 and 17 billion USD, the margin consistently improved, suggesting a structural optimization of the cost of goods sold or a strategic pivot toward more profitable revenue streams. The period concludes with a slight moderation to 73.51% in March 2026.

The operating profit margin exhibits a volatile trajectory over the analyzed period, characterized by an initial phase of expansion, a severe contraction into negative territory, and a subsequent recovery toward a stable baseline.

Initial Margin Expansion (2022)

A consistent upward trend is observed throughout 2022, with the operating profit margin increasing from 26.12% in April to a peak of 34.83% by December. This growth coincided with the highest recorded revenue levels in the dataset, indicating a period of high operational efficiency and strong profitability.

Operational Contraction and Trough (2023 – Mid-2024)

A sharp decline in profitability occurred starting in 2023. The margin fell from 34.44% in April 2023 to 2.15% by December 2023, eventually reaching a nadir of -4.19% in June 2024. This period is marked by a significant drop in revenues and a transition of operating income into negative values during the latter half of 2023, reflecting a substantial increase in operating costs relative to income.

Recovery and Stabilization (Late 2024 – 2026)

A recovery phase began in September 2024, as the operating profit margin returned to positive territory at 9.56%. From December 2024 through March 2026, the margin demonstrated a steady climb and stabilization, fluctuating within a range of 19.29% to 23.23%. This suggests a successful realignment of operating expenses and a return to sustainable profitability levels.

The net profit margin exhibits significant volatility over the analyzed period, characterized by an initial period of high profitability, a sharp contraction into negative territory, and a subsequent phase of recovery and stabilization.

Peak Profitability Trend

Between April 2022 and April 2023, profit margins remained consistently high, peaking at 31.27% in December 2022. This phase was supported by revenues consistently exceeding 18 billion US dollars and strong quarterly net income levels.

Margin Contraction and Negative Returns

A precipitous decline is observed starting in July 2023, where the net profit margin fell from 27.38% to 3.56% by December 2023. This downward trajectory reached its lowest point in June 2024, with the margin contracting to -4.62%, reflecting a period where net losses were recorded despite fluctuating revenue streams.

Recovery and Stabilization Phase

A recovery trend emerged in the second half of 2024, with margins returning to positive territory and reaching 12.62% by December 2024. Profitability continued to improve through the first half of 2025, peaking at 16.84% in March 2025. Despite a dip to 12.42% in December 2025, the margin shows a stabilizing trend, concluding the period at 11.83% in March 2026.

The Return on Equity (ROE) demonstrates a significant downward trajectory from early 2022 through the first half of 2024, followed by a period of moderate stabilization. After peaking at 33.61% in July 2022, the ratio experienced a precipitous decline, reaching its lowest point in June 2024 at -2.96%. From mid-2024 through March 2026, the ROE normalized within a range of 8.31% to 12.12%, representing a substantial contraction from the high-performance levels observed at the start of the period.

Net Income Volatility

Profitability exhibited extreme fluctuations, beginning with strong quarterly results exceeding 7.8 billion USD in 2022 and peaking at 9.9 billion USD in July 2022. A sharp reversal occurred in late 2023, with net losses reaching 3.3 billion USD by December 2023. While profitability generally returned to positive territory in 2024 and 2025, periodic volatility persisted, including a net loss of 1.6 billion USD in December 2025.

Shareholders' Equity Trends

Total shareholders' equity grew from 82.4 billion USD in April 2022 to a peak of 100.9 billion USD in April 2023. Subsequently, equity levels fluctuated between 86.4 billion USD and 92.8 billion USD. This relatively stable equity base meant that the dramatic shifts in ROE were primarily driven by volatility in net income rather than significant changes in the capital structure.

ROE Recovery and Stabilization

Following the negative trough in early 2024, a recovery phase began in July 2024 with an ROE of 4.61%. The ratio climbed to 12.12% by June 2025 before settling into a range between 8% and 11% through March 2026. This indicates a transition from the exceptional profitability of 2022 to a more modest and consistent return profile.

The Return on Assets (ROA) demonstrates a pronounced cyclical trajectory, characterized by a period of high efficiency in 2022, a sharp decline into negative territory by early 2024, and a subsequent partial recovery through the first quarter of 2026.

Profitability Peak and Contraction

ROA reached its zenith between April and December 2022, peaking at 15.91%. This performance was driven by strong net income figures that consistently exceeded $8 billion per quarter for the majority of the year. However, a downward trend emerged in 2023, where ROA fell precipitously from 14.85% in April to 0.94% by December, correlating with a significant decrease in net income.

Period of Negative Returns

The decline culminated in the first half of 2024, with ROA dipping into negative values and reaching a low of -1.20% in June 2024. This period reflects the impact of substantial net losses recorded in late 2023, which continued to weigh on profitability metrics as the organization navigated a period of financial contraction.

Recovery and Stabilization

A recovery trend began in the third quarter of 2024, with ROA returning to positive figures and climbing to a secondary peak of 5.22% in June 2025. Despite a temporary dip in December 2025, the ratio stabilized between 3.61% and 3.73% by March 2026, indicating a lower but more consistent level of asset efficiency compared to the levels seen in 2022.

Asset Base Influence

Total assets expanded from $183.8 billion in April 2022 to a peak of $226.5 billion in December 2023. The synchronization of an expanding asset base with declining net income during 2023 acted as a primary driver for the rapid compression of the ROA, as more capital was deployed without a corresponding increase in earnings.